Chemicals: Q1 FY27 results (April-June 2026)

83 companies have declared Chemicals Q1 FY27 results so far, the latest on 14 Aug 2026.

Across the 83 non-financial companies with a year-ago quarter to compare, sales grew +25.3% and net profit +46.5% year on year, and the combined operating margin widened 300 bps to 17.9%.

80% of companies grew net profit; 3 turned a loss into a profit; 69% beat their own profit trend and 17% fell short of it.

Updated 12 Oct 2026, 14:33 IST 83 declared 112 due in the next 3 days →

Chemicals Q1 FY27 scoreboard

Sales growth
+25.3%
YoY, 83 companies combined; median +22.3%
Net profit growth
+46.5%
YoY combined; median +60.1%
Operating margin
17.9%
+300 bps YoY
Grew profit
80%
3 turnarounds, 2 into loss
Vs own profit trend
69% / 17%
above / below, 14% in line
Price since results
-2.7%
median; 42% of 74 stocks up
Other-income heavy
11
25%+ of pre-tax profit from other income & one-offs

Latest Chemicals Q1 FY27 results 83

Page 3 of 3

Fairchem Organics Limited

FAIRCHEMOR · Chemicals · Q1 FY27 · Standalone · Filed
M Cap
₹943 Cr
P/E
65.6
PEG
—
Since results
-1.2%
  • Profit +999% above its own trend
  • Operating margin expanded 615 bps YoY
  • Core business grew faster than reported profit (core profit +798%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +34.4%+50.6% 176117131
Operating profit +241.6%+122.5% 17.98.05.2
OPM % +615 bps+328 bps 10.1%6.9%4.0%
Other income +167.3%-35.6% 0.30.50.1
Net profit +755.9%+171.4% 10.03.71.2
PAT margin % +479 bps+253 bps 5.7%3.2%0.9%
EPS (₹) +783.3%+180.9% 7.952.830.90

Quality of profit

Core 98%Other income & one-offs 2%

Pre-tax profit ₹13.6 Cr: core business ₹13.3 Cr, other income ₹0.3 Cr.

Core profit YoY: +797.9% · reported profit +755.9%

Cash & debt

FY26 cash from operations ₹42.0 Cr: 759% of FY26 net profit of ₹5.5 Cr.

Borrowings ₹84.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹110₹176 +59.4% above
Net profit₹0.6₹10.0 +999.0% above
AI read of the filing 755% YoY PAT Growth: Fairchem Organics Reports Strong Q1 FY27 Results Positive
  • Revenue from operations grew 34.4% YoY to ₹176.15 cr and 50.6% QoQ from ₹116.93 cr.
  • Net profit (PAT) reached ₹10.01 cr, a massive jump from ₹1.17 cr in June 2025.
  • Quarterly EPS stood at ₹7.95, compared to ₹0.90 in the same quarter last year.
Full analysis →

Neogen Chemicals Limited

NEOGEN · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹7,145 Cr
P/E
200.9
PEG
—
Since results
+18.6%
  • Profit +164% above its own trend
  • Operating margin expanded 240 bps YoY
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +34.0%+1.5% 250247187
Operating profit +53.1%+9.8% 48.243.931.5
OPM % +240 bps+146 bps 19.3%17.8%16.9%
Other income +230.1%+314.3% 4.11.01.2
Net profit +66.8%+50.2% 17.111.410.3
PAT margin % +134 bps+222 bps 6.8%4.6%5.5%
EPS (₹) +61.7%+45.6% 6.294.323.89

Quality of profit

Core 83%Other income & one-offs 17%

Pre-tax profit ₹23.3 Cr: core business ₹19.2 Cr, other income ₹4.1 Cr.

Core profit YoY: +47.2% · reported profit +66.8%

Cash & debt

FY26 cash from operations −₹231 Cr: -805% of FY26 net profit of ₹28.7 Cr.

Borrowings ₹1,395 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹203₹250 +23.5% above
Net profit₹6.5₹17.1 +164.0% above
AI read of the filing Neogen Chemicals approves Rs 600 Cr fundraise and sets Aug 13 as dividend record date Positive
  • Approved fundraise of up to Rs 600 crore via QIP or other permissible modes
  • Set August 13, 2026, as the record date for final dividend eligibility
  • Subsidiary Neogen Morita New Materials to increase borrowing powers to Rs 500 crore
Full analysis →

Atul Limited

ATUL · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹17,319 Cr
P/E
21.4
PEG
2.37
Since results
-2.8%
  • Profit +42% above its own trend
  • Operating margin expanded 533 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +25.0%+10.7% 1,8481,6701,478
Operating profit +66.8%+40.0% 394281236
OPM % +533 bps+447 bps 21.3%16.8%16.0%
Other income +19.0%-63.8% 33.392.028.0
Net profit +91.8%+20.3% 254211132
PAT margin % +479 bps+111 bps 13.7%12.6%9.0%
EPS (₹) +92.0%+16.7% 83.3271.3843.40

Quality of profit

Core 90%Other income & one-offs 10%

Pre-tax profit ₹347 Cr: core business ₹311 Cr, other income ₹33.3 Cr, exceptional & other items ₹2.1 Cr.

Core profit YoY: +109.0% · reported profit +91.8%

Cash & debt

FY26 cash from operations ₹1,023 Cr: 148% of FY26 net profit of ₹689 Cr.

Borrowings ₹183 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1,650₹1,848 +12.0% above
Net profit₹179₹254 +41.9% above
AI read of the filing 92% YoY PAT Growth: Atul Ltd Reports Strong Q1 FY27 Results; Appoints New Director Positive
  • Consolidated revenue from operations increased 25% YoY to ₹1,847.95 Cr from ₹1,478.00 Cr.
  • Consolidated Net Profit jumped 91.8% YoY to ₹253.93 Cr compared to ₹132.36 Cr in Q1 FY26.
  • Consolidated EPS for the quarter stood at ₹83.32, nearly doubling from ₹43.40 YoY.
Full analysis →

GP Petroleums Limited

GULFPETRO · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹314 Cr
P/E
—
PEG
—
Since results
+43.1%
  • Profit +234% above its own trend
  • Operating margin expanded 600 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +45.8%+41.6% 230163158
Operating profit +184.0%+126.6% 28.412.510.0
OPM % +600 bps+462 bps 12.3%7.7%6.3%
Other income +36.2%+60.2% 1.40.81.0
Net profit +243.1%+120.6% 20.69.36.0
PAT margin % +514 bps+320 bps 8.9%5.7%3.8%
EPS (₹) +220.6%+120.8% 4.041.831.26

Quality of profit

Core 97%Other income & one-offs 3%

Pre-tax profit ₹27.6 Cr: core business ₹26.9 Cr, other income ₹1.4 Cr, exceptional & other items −₹0.6 Cr.

Core profit YoY: +198.5% · reported profit +243.1%

Cash & debt

FY26 cash from operations ₹44.0 Cr.

Borrowings ₹23.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹146₹230 +58.2% above
Net profit₹6.2₹20.6 +234.4% above
AI read of the filing GP Petroleums Q1 PAT Surges 229% to ₹21.19 Cr; ₹0.50 Dividend Recommended Positive
  • Revenue from operations increased 45.5% YoY to ₹230.33 Cr from ₹158.30 Cr in June 2025.
  • Net profit after tax jumped to ₹21.19 Cr, representing approximately 73% of the entire previous TTM PAT in a single quarter.
  • Manufacturing segment revenue grew significantly to ₹182.34 Cr from ₹122.68 Cr in the year-ago period.
Full analysis →

Gujarat Alkalies and Chemicals Limited

GUJALKALI · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹4,446 Cr
P/E
67.0
PEG
—
Since results
-6.7%
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 921 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +12.6%+10.7% 1,2451,1251,105
Operating profit +133.3%+101.5% 22211095.0
OPM % +921 bps+803 bps 17.8%9.8%8.6%
Other income -4.4%-69.4% 7.725.08.0
Net profit from loss+266.5% 55.015.0-13.8
PAT margin % +566 bps+308 bps 4.4%1.3%-1.2%
EPS (₹) from loss+267.2% 7.492.04-1.88

Quality of profit

Core 92%Other income & one-offs 8%

Pre-tax profit ₹112 Cr: core business ₹102 Cr, other income ₹7.7 Cr, exceptional & other items ₹1.6 Cr.

Core profit YoY: from loss

Cash & debt

FY26 cash from operations ₹406 Cr.

Borrowings ₹575 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1,182₹1,245 +5.3% above
AI read of the filing ₹54.98 Cr Q1 Net Profit: GUJALKALI reports turnaround and ₹55 Cr HCL unit expansion Positive
  • Consolidated Net Profit reached ₹54.98 Cr in Q1 FY27, reversing a loss of ₹13.78 Cr in Q1 FY26.
  • Revenue from operations increased to ₹1,244.91 Cr, up 12.6% from ₹1,105.12 Cr in the previous year's quarter.
  • Approved ₹55 Cr investment for a new HCL synthesis unit at Dahej to enhance chlorine disposal and caustic soda output.
Full analysis →

Fineotex Chemical Limited

FCL · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹6,747 Cr
P/E
45.5
PEG
6.50
Since results
+34.6%
  • Profit +99% above its own trend
  • Operating margin contracted 268 bps YoY
  • Core business grew faster than reported profit (core profit +145%)
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +174.8%+20.0% 377314137
Operating profit +134.7%+35.4% 59.143.725.2
OPM % -268 bps+178 bps 15.7%13.9%18.4%
Other income +10.3%+6.7% 10.19.59.1
Net profit +92.6%+10.1% 48.243.825.0
PAT margin % -546 bps-116 bps 12.8%14.0%18.3%
EPS (₹) -81.2%+7.9% 0.410.382.18

Quality of profit

Core 84%Other income & one-offs 16%

Pre-tax profit ₹64.7 Cr: core business ₹54.7 Cr, other income ₹10.1 Cr.

Core profit YoY: +144.5% · reported profit +92.6%

Cash & debt

FY26 cash from operations −₹24.0 Cr: -19% of FY26 net profit of ₹125 Cr.

Borrowings ₹8.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹166₹377 +126.6% above
Net profit₹24.3₹48.2 +98.6% above
AI read of the filing 164% Revenue Growth in Q1 FY27; Consolidated PAT Rises 93% to ₹48.21 Cr Positive
  • Consolidated Revenue from Operations grew 164.48% YoY to ₹376.63 Cr
  • Consolidated PAT increased 92.61% YoY to ₹48.21 Cr from ₹25.03 Cr
  • Sales volumes surged by 130.84% on a YoY basis
Full analysis →

SRF Limited

SRF · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹74,680 Cr
P/E
34.5
PEG
—
Since results
-15.2%
  • Operating margin expanded 284 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +31.8%+9.1% 5,0334,6153,819
Operating profit +49.0%+20.5% 1,2371,026830
OPM % +284 bps+234 bps 24.6%22.2%21.7%
Other income +16.4%+160.8% 33.913.029.1
Net profit +75.5%+30.4% 759582432
PAT margin % +376 bps+247 bps 15.1%12.6%11.3%
EPS (₹) +75.6%+30.4% 25.6019.6314.58

Quality of profit

Core 96%Other income & one-offs 4%

Pre-tax profit ₹979 Cr: core business ₹945 Cr, other income ₹33.9 Cr.

Core profit YoY: +72.9% · reported profit +75.5%

Cash & debt

FY26 cash from operations ₹2,554 Cr: 139% of FY26 net profit of ₹1,836 Cr.

Borrowings ₹5,083 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹4,073₹5,033 +23.6% above
Net profit₹716₹759 +6.0% in line
AI read of the filing SRF Q1 FY27: Net Profit Surges 42.6% YoY to ₹566 Cr; ₹5/share Interim Dividend Declared Positive
  • Standalone Net Profit increased 42.6% YoY to ₹566.30 Cr from ₹397.00 Cr in Q1 FY26.
  • Standalone Revenue from operations grew 25% YoY to ₹3,801.97 Cr.
  • Operating Margin improved to 20.82% compared to 17.17% in the same quarter last year.
Full analysis →

Jubilant Ingrevia Limited

JUBLINGREA · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹9,870 Cr
P/E
32.1
PEG
—
Since results
-17.9%
  • Profit +21% above its own trend
  • Operating margin expanded 162 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +25.3%+10.3% 1,3001,1791,038
Operating profit +40.1%+22.2% 199163142
OPM % +162 bps+149 bps 15.3%13.8%13.7%
Other income -8.9%+13.6% 10.29.011.2
Net profit +40.9%+23.0% 10686.075.1
PAT margin % +90 bps+84 bps 8.1%7.3%7.2%
EPS (₹) +41.1%+23.4% 6.705.434.75

Quality of profit

Core 93%Other income & one-offs 7%

Pre-tax profit ₹141 Cr: core business ₹131 Cr, other income ₹10.2 Cr.

Core profit YoY: +47.5% · reported profit +40.9%

Cash & debt

FY26 cash from operations ₹524 Cr: 189% of FY26 net profit of ₹277 Cr.

Borrowings ₹792 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1,082₹1,300 +20.1% above
Net profit₹87.5₹106 +20.9% above
AI read of the filing Rs 1,300 Cr Revenue: Jubilant Ingrevia Reports Strong Q1 FY27 with 44% YoY EPS Growth Positive
  • Revenue from operations reached Rs 1,300.27 Cr, a 26.9% increase over the Rs 1,024.34 Cr reported in June 2025
  • EPS grew 43.9% YoY to Rs 5.83 from Rs 4.05 in the corresponding previous year quarter
  • Net profit margin improved to 5.83% from 4.05% YoY and 5.08% in the preceding March 2026 quarter
Full analysis →

Alkali Metals Limited

ALKALI · Chemicals · Q1 FY27 · Standalone · Filed
M Cap
₹91.0 Cr
P/E
84.6
PEG
—
Since results
+8.0%
  • Operating margin contracted 947 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales -14.8%-38.9% 17.628.720.6
Operating profit to lossto loss -0.36.11.6
OPM % -947 bps-2311 bps -2.0%21.2%7.5%
Other income —+176.4% 0.80.30.0
Net profit loss narrowedto loss -0.64.0-1.1
PAT margin % +191 bps-1766 bps -3.7%14.0%-5.6%
EPS (₹) loss narrowedto loss -0.633.95-1.13

Quality of profit

Pre-tax profit −₹0.6 Cr: core business −₹1.4 Cr, other income ₹0.8 Cr.

Core profit YoY: to loss

Cash & debt

FY26 cash from operations ₹2.8 Cr: 495% of FY26 net profit of ₹0.6 Cr.

Borrowings ₹17.9 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹23.4₹17.6 -24.9% below

Rossari Biotech Limited

ROSSARI · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹2,270 Cr
P/E
15.0
PEG
1.25
Since results
-23.7%
  • FY26 operating cash flow was only 44% of profit
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +28.2%+1.8% 697685544
Operating profit +18.8%+4.7% 80.677.067.9
OPM % -92 bps+32 bps 11.6%11.2%12.5%
Other income +203.7%-81.8% 3.620.01.2
Net profit +4.5%-23.7% 35.146.033.6
PAT margin % -115 bps-168 bps 5.0%6.7%6.2%
EPS (₹) +4.4%-23.6% 6.348.306.07

Quality of profit

Core 92%Other income & one-offs 8%

Pre-tax profit ₹47.7 Cr: core business ₹44.0 Cr, other income ₹3.6 Cr.

Core profit YoY: -0.8% · reported profit +4.5%

Cash & debt

FY26 cash from operations ₹65.0 Cr: 44% of FY26 net profit of ₹149 Cr.

Borrowings ₹436 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹628₹697 +11.0% above
Net profit₹35.0₹35.1 +0.4% in line
AI read of the filing Rs 482.3 Cr Q1 Standalone Revenue for Rossari Biotech, Up 31.8% YoY; Overseas Restructuring Set Positive
  • Standalone Revenue for Q1 FY27 grew 31.8% YoY to Rs 482.3 Cr from Rs 365.8 Cr.
  • Standalone Profit After Tax (PAT) rose 30.6% YoY to Rs 34.3 Cr.
  • Sequential (QoQ) PAT saw a sharp decline of 37.4% from Rs 54.7 Cr in the preceding March quarter.
Full analysis →

Chembond Material Technologies Limited

CHEMBOND · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹255 Cr
P/E
17.4
PEG
—
Since results
+10.1%
  • Profit +136% above its own trend
  • Operating margin contracted 191 bps YoY
  • 65% of pre-tax profit came from other income and one-off items
  • Profit grew faster than the core business (core profit -24%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +25.5%+0.9% 72.471.857.7
Operating profit -14.3%-53.8% 3.06.43.5
OPM % -191 bps-487 bps 4.1%9.0%6.0%
Other income +42.1%from loss 3.8-1.22.6
Net profit +43.5%+64.5% 5.73.54.0
PAT margin % +99 bps+306 bps 7.9%4.8%6.9%
EPS (₹) +43.0%+63.8% 4.262.602.98

Quality of profit

Core 35%Other income & one-offs 65%

Pre-tax profit ₹5.8 Cr: core business ₹2.1 Cr, other income ₹3.8 Cr.

Core profit YoY: -24.1% · reported profit +43.5%

Cash & debt

FY26 cash from operations ₹15.0 Cr: 116% of FY26 net profit of ₹12.9 Cr.

Borrowings ₹4.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹74.7₹72.4 -3.1% in line
Net profit₹2.4₹5.7 +135.7% above
AI read of the filing 25.5% YoY Revenue Growth; Chembond Reports Rs 5.73 Cr Consolidated PAT in Q1 FY27 Positive
  • Consolidated revenue increased by 25.5% YoY to Rs 72.42 Cr from Rs 57.68 Cr in Q1 FY26
  • Consolidated PAT grew 43.6% YoY to Rs 5.73 Cr compared to Rs 3.99 Cr in the same period last year
  • Basic EPS improved to Rs 4.26 from Rs 2.97 in Q1 FY26
Full analysis →

Tatva Chintan Pharma Chem Limited

TATVA · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹4,222 Cr
P/E
82.8
PEG
—
Since results
+30.8%
  • Profit +14% above its own trend
  • Operating margin expanded 480 bps YoY
  • Exceptional items of ₹1.3 Cr in the quarter
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +42.8%+24.7% 167134117
Operating profit +90.0%+15.3% 32.328.017.0
OPM % +480 bps-156 bps 19.3%20.9%14.5%
Other income +178.0%— 2.80.01.0
Net profit +128.3%+59.8% 16.010.07.0
PAT margin % +358 bps+210 bps 9.6%7.5%6.0%
EPS (₹) +140.5%+54.9% 6.834.412.84

Quality of profit

Core 93%Other income & one-offs 7%

Pre-tax profit ₹21.1 Cr: core business ₹19.6 Cr, other income ₹2.8 Cr, exceptional & other items −₹1.3 Cr.

Core profit YoY: +145.6% · reported profit +128.3%

Cash & debt

FY26 cash from operations ₹31.0 Cr: 74% of FY26 net profit of ₹42.0 Cr.

Borrowings ₹120 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹160₹167 +4.3% in line
Net profit₹14.0₹16.0 +14.1% above
AI read of the filing Tatva Chintan Q1 PAT Doubles YoY; Announces Rs 200 Cr Greenfield Expansion Positive
  • Standalone Revenue for Q1 FY27 rose to Rs 146.70 Cr, up from Rs 109.18 Cr in the same quarter last year.
  • Standalone PAT for the quarter stood at Rs 10.45 Cr, a 103.7% increase compared to Rs 5.13 Cr in Q1 FY26.
  • Approved a new greenfield unit at Dahej-III with a proposed capacity addition of 344 KL, exceeding the current 280 KL capacity.
Full analysis →

Himadri Speciality Chemical Limited

HSCL · Chemicals · Q1 FY27 · Consolidated · Filed
M Cap
₹33,299 Cr
P/E
41.4
PEG
0.88
Since results
-3.1%
  • Operating margin contracted 180 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +28.0%+11.2% 1,4321,2881,118
Operating profit +17.5%+19.0% 288242245
OPM % -180 bps+132 bps 20.1%18.8%21.9%
Other income +111.1%-9.2% 56.362.026.7
Net profit +27.4%+9.8% 228208179
PAT margin % -9 bps-20 bps 16.0%16.1%16.0%
EPS (₹) +23.6%+14.3% 4.553.983.68

Quality of profit

Core 81%Other income & one-offs 19%

Pre-tax profit ₹301 Cr: core business ₹244 Cr, other income ₹56.3 Cr.

Core profit YoY: +13.8% · reported profit +27.4%

Cash & debt

FY26 cash from operations ₹382 Cr: 51% of FY26 net profit of ₹756 Cr.

Borrowings ₹770 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1,107₹1,432 +29.4% above
Net profit₹242₹228 -5.7% in line
AI read of the filing HSCL approves ₹368 Cr capex for high-value specialty chemicals and India's first CNT facility Positive
  • ₹128 Cr additional capex to double Anthraquinone and Carbazole capacity from 2,600 to 5,300 MTPA
  • ₹70 Cr investment for India's first 200 MTPA Carbon Nano Tubes (CNT) facility using in-house technology
  • ₹170 Cr for 6,000 MTPA Super Speciality Carbon Black conversion expected by Q4 FY28
Full analysis →

Plastiblends India Limited

PLASTIBLEN · Chemicals · Q1 FY27 · Standalone · Filed
M Cap
₹524 Cr
P/E
14.3
PEG
—
Since results
+4.6%
  • Profit +63% above its own trend
  • Operating margin expanded 316 bps YoY
  • Core business grew faster than reported profit (core profit +91%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +11.0%+5.0% 222211200
Operating profit +63.0%+15.7% 22.019.013.5
OPM % +316 bps+91 bps 9.9%9.0%6.8%
Other income -6.1%-40.8% 2.44.02.5
Net profit +67.5%+6.8% 15.014.08.9
PAT margin % +228 bps+11 bps 6.7%6.6%4.5%
EPS (₹) +67.6%+7.9% 5.755.333.43

Quality of profit

Core 88%Other income & one-offs 12%

Pre-tax profit ₹20.2 Cr: core business ₹17.9 Cr, other income ₹2.4 Cr.

Core profit YoY: +90.6% · reported profit +67.5%

Cash & debt

FY26 cash from operations ₹21.0 Cr: 58% of FY26 net profit of ₹35.9 Cr.

Borrowings ₹22.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹205₹222 +8.2% above
Net profit₹9.2₹15.0 +62.6% above
AI read of the filing 67.5% PAT Growth in Q1 FY27; EBITDA Margins Expand 297 bps to 10.98% Positive
  • Revenue from operations increased 11.01% YoY to  221.61 Cr from  199.63 Cr.
  • Net Profit (PAT) grew 67.54% YoY to  14.95 Cr compared to  8.92 Cr in Q1 FY26.
  • EBITDA margins expanded significantly by 297 basis points YoY to reach 10.98%.
Full analysis →

Privi Speciality Chemicals Limited

PRIVISCL · Chemicals · Q1 FY27 · Consolidated
M Cap
₹13,375 Cr
P/E
39.1
PEG
0.27
  • Profit -18% below its own trend
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +19.2%-7.8% 666722559
Operating profit +15.1%-15.6% 152180132
OPM % -81 bps-211 bps 22.8%24.9%23.6%
Other income +66.9%+275.0% 15.04.09.0
Net profit +44.2%-11.7% 83.094.057.6
PAT margin % +216 bps-56 bps 12.5%13.0%10.3%
EPS (₹) +35.9%-10.1% 21.5423.9615.85

Quality of profit

Core 87%Other income & one-offs 13%

Pre-tax profit ₹113 Cr: core business ₹98.0 Cr, other income ₹15.0 Cr.

Core profit YoY: +35.7% · reported profit +44.2%

Cash & debt

FY26 cash from operations ₹550 Cr: 174% of FY26 net profit of ₹316 Cr.

Borrowings ₹1,021 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹681₹666 -2.2% in line
Net profit₹101₹83.0 -17.9% below

Clean Science and Technology Limited

CLEAN · Chemicals · Q1 FY27 · Consolidated
M Cap
₹8,443 Cr
P/E
36.4
PEG
—
  • Profit +11% above its own trend
  • Operating margin contracted 995 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +21.9%+7.6% 268249220
Operating profit -4.6%+0.0% 96.096.0101
OPM % -995 bps-273 bps 35.8%38.6%45.8%
Other income +70.2%+633.3% 22.03.012.9
Net profit -4.7%+25.9% 73.058.076.6
PAT margin % -758 bps+395 bps 27.2%23.3%34.8%
EPS (₹) -4.3%+25.9% 6.905.487.21

Quality of profit

Core 76%Other income & one-offs 24%

Pre-tax profit ₹98.0 Cr: core business ₹75.0 Cr, other income ₹22.0 Cr, exceptional & other items ₹1.0 Cr.

Core profit YoY: -16.2% · reported profit -4.7%

Cash & debt

FY26 cash from operations ₹275 Cr: 117% of FY26 net profit of ₹236 Cr.

Borrowings ₹2.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹212₹268 +26.2% above
Net profit₹65.7₹73.0 +11.1% above

J.G.Chemicals Limited

JGCHEM · Chemicals · Q1 FY27 · Consolidated
M Cap
₹2,472 Cr
P/E
31.6
PEG
4.51
  • Profit +56% above its own trend
  • Operating margin expanded 168 bps YoY
  • Core business grew faster than reported profit (core profit +79%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +44.9%+10.4% 316286218
Operating profit +71.7%+58.2% 34.021.519.8
OPM % +168 bps+325 bps 10.8%7.5%9.1%
Other income -12.2%-44.0% 3.05.43.4
Net profit +58.9%+37.6% 26.018.916.4
PAT margin % +72 bps+162 bps 8.2%6.6%7.5%
EPS (₹) +58.8%+38.8% 6.404.614.03

Quality of profit

Core 94%Other income & one-offs 6%

Pre-tax profit ₹35.0 Cr: core business ₹33.0 Cr, other income ₹3.0 Cr, exceptional & other items −₹1.0 Cr.

Core profit YoY: +79.1% · reported profit +58.9%

Cash & debt

FY26 cash from operations ₹44.0 Cr: 64% of FY26 net profit of ₹68.7 Cr.

Borrowings ₹6.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹247₹316 +28.1% above
Net profit₹16.7₹26.0 +55.6% above

Veedol Corporation Limited

VEEDOL · Chemicals · Q1 FY27 · Consolidated
M Cap
₹2,298 Cr
P/E
11.2
PEG
0.59
  • Profit +28% above its own trend
  • Operating margin expanded 465 bps YoY
  • Core business grew faster than reported profit (core profit +79%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +18.6%+0.3% 609607514
Operating profit +66.8%+55.6% 98.063.058.8
OPM % +465 bps+571 bps 16.1%10.4%11.4%
Other income +108.7%+0.0% 12.012.05.8
Net profit +57.0%+36.8% 78.057.049.7
PAT margin % +314 bps+342 bps 12.8%9.4%9.7%
EPS (₹) +53.0%+35.6% 44.7232.9829.23

Quality of profit

Core 88%Other income & one-offs 12%

Pre-tax profit ₹102 Cr: core business ₹90.0 Cr, other income ₹12.0 Cr.

Core profit YoY: +78.6% · reported profit +57.0%

Cash & debt

FY26 cash from operations ₹194 Cr: 110% of FY26 net profit of ₹177 Cr.

Borrowings ₹16.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹562₹609 +8.4% above
Net profit₹60.7₹78.0 +28.4% above

Indo Borax & Chemicals Limited

INDOBORAX · Chemicals · Q1 FY27 · Consolidated
M Cap
₹1,528 Cr
P/E
27.1
PEG
—
  • Profit +29% above its own trend
  • Operating margin expanded 578 bps YoY
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +30.7%+11.1% 70.063.053.6
Operating profit +63.8%+53.8% 20.013.012.2
OPM % +578 bps+794 bps 28.6%20.6%22.8%
Other income +7.5%-40.0% 3.05.02.8
Net profit +59.4%+6.7% 16.015.010.0
PAT margin % +412 bps-95 bps 22.9%23.8%18.7%
EPS (₹) +61.7%+11.7% 5.064.533.13

Quality of profit

Core 91%Other income & one-offs 9%

Pre-tax profit ₹22.0 Cr: core business ₹20.0 Cr, other income ₹3.0 Cr, exceptional & other items −₹1.0 Cr.

Core profit YoY: +76.1% · reported profit +59.4%

Cash & debt

FY26 cash from operations ₹87.0 Cr: 173% of FY26 net profit of ₹50.4 Cr.

Borrowings ₹1.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹63.0₹70.0 +11.2% above
Net profit₹12.4₹16.0 +29.1% above

Valiant Organics Limited

VALIANTORG · Chemicals · Q1 FY27 · Consolidated
M Cap
₹1,311 Cr
P/E
24.0
PEG
—
  • Profit +91% above its own trend
  • Operating margin expanded 596 bps YoY
  • 27% of pre-tax profit came from other income and one-off items
  • Profit grew faster than the core business (core profit +187%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +13.5%+6.4% 232218204
Operating profit +69.2%+61.5% 42.026.024.8
OPM % +596 bps+618 bps 18.1%11.9%12.1%
Other income +924.0%+120.0% 11.05.01.1
Net profit +282.7%+81.2% 29.016.07.6
PAT margin % +879 bps+516 bps 12.5%7.3%3.7%
EPS (₹) +282.3%+84.7% 10.365.612.71

Quality of profit

Core 73%Other income & one-offs 27%

Pre-tax profit ₹37.0 Cr: core business ₹27.0 Cr, other income ₹11.0 Cr, exceptional & other items −₹1.0 Cr.

Core profit YoY: +187.0% · reported profit +282.7%

Cash & debt

FY26 cash from operations ₹92.0 Cr: 277% of FY26 net profit of ₹33.2 Cr.

Borrowings ₹256 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹210₹232 +10.7% above
Net profit₹15.2₹29.0 +91.3% above

Indo Amines Limited

INDOAMIN · Chemicals · Q1 FY27 · Consolidated
M Cap
₹1,145 Cr
P/E
14.0
PEG
0.56
  • Profit -23% below its own trend
  • Operating margin expanded 325 bps YoY
  • Core business grew faster than reported profit (core profit +105%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +30.4%+17.9% 375318288
Operating profit +69.3%+55.9% 53.034.031.3
OPM % +325 bps+344 bps 14.1%10.7%10.9%
Other income -93.6%-83.3% 1.06.015.5
Net profit +7.5%+47.6% 31.021.028.8
PAT margin % -176 bps+166 bps 8.3%6.6%10.0%
EPS (₹) +7.6%+49.8% 4.242.833.94

Quality of profit

Core 98%Other income & one-offs 2%

Pre-tax profit ₹42.0 Cr: core business ₹41.0 Cr, other income ₹1.0 Cr.

Core profit YoY: +104.7% · reported profit +7.5%

Cash & debt

FY26 cash from operations ₹79.0 Cr: 99% of FY26 net profit of ₹79.8 Cr.

Borrowings ₹311 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹310₹375 +20.9% above
Net profit₹40.2₹31.0 -22.9% below

OCCL Limited

OCCLLTD · Chemicals · Q1 FY27 · Standalone
M Cap
₹1,092 Cr
P/E
14.7
PEG
0.01
  • Profit +149% above its own trend
  • Operating margin expanded 704 bps YoY
  • FY26 operating cash flow was only 23% of profit
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +78.9%+47.7% 220149123
Operating profit +138.5%+158.3% 62.024.026.0
OPM % +704 bps+1207 bps 28.2%16.1%21.1%
Other income —+0.0% 2.02.00.0
Net profit +207.7%+110.5% 40.019.013.0
PAT margin % +761 bps+543 bps 18.2%12.8%10.6%
EPS (₹) +206.5%+108.3% 8.063.872.63

Quality of profit

Core 98%Other income & one-offs 2%

Pre-tax profit ₹54.0 Cr: core business ₹53.0 Cr, other income ₹2.0 Cr, exceptional & other items −₹1.0 Cr.

Core profit YoY: +194.4% · reported profit +207.7%

Cash & debt

FY26 cash from operations ₹11.0 Cr: 23% of FY26 net profit of ₹47.2 Cr.

Borrowings ₹84.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹147₹220 +50.1% above
Net profit₹16.1₹40.0 +148.5% above

Primo Chemicals Limited

PRIMO · Chemicals · Q1 FY27 · Consolidated
M Cap
₹637 Cr
P/E
39.9
PEG
—
  • Profit +129% above its own trend
  • 59% of pre-tax profit came from other income and one-off items
  • Core business grew faster than reported profit (core profit +99%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales -1.2%-3.2% 140145142
Operating profit +2.0%+9.4% 20.819.020.4
OPM % +46 bps+170 bps 14.8%13.1%14.4%
Other income -0.6%-7.4% 5.25.75.3
Net profit +14.7%-22.9% 4.76.14.1
PAT margin % +46 bps-85 bps 3.3%4.2%2.9%
EPS (₹) +11.8%-24.0% 0.190.250.17

Quality of profit

Core 41%Other income & one-offs 59%

Pre-tax profit ₹8.9 Cr: core business ₹3.6 Cr, other income ₹5.2 Cr.

Core profit YoY: +98.9% · reported profit +14.7%

Against its own trend ?

TrendActualGap
Sales₹140₹140 -0.0% in line
Net profit₹2.0₹4.7 +129.4% above

How to read this page

The numbers. Each card is one company's Q1 FY27 results as filed with NSE or BSE, read from the filing within hours of its release, in ₹ crore. We show the consolidated statement, or the standalone one when the consolidated figures are a copy of it or have no year-ago quarter to compare with. YoY compares with the same quarter a year earlier and QoQ with the quarter before (the previous half-year for companies that report every six months). A swing between profit and loss is described in words: a percentage across it would mislead.

Margins. Operating margin (OPM) is operating profit, before depreciation, interest and other income, as a share of sales; PAT margin is net profit as a share of sales. Their changes are in basis points (100 bps = 1 percentage point).

Quality of profit. Core profit is operating profit minus interest and depreciation: what the business itself earned before tax. The rest of pre-tax profit is other income (interest on cash, dividends, gains on investments) and exceptional or one-off items. We flag a quarter when that share is 25% or more, and when reported profit grew much faster than core profit. For banks we compare pre-provision profit with net profit, since a fall in provisions can lift profit without the business growing.

Against its own trend. We do not have analyst consensus estimates, and we do not make them up. Instead each company is measured against the path it was on: the same quarter last year, grown at the median of its last four year-on-year growth rates (held between −50% and +100%; at least two growth rates needed). Sales 5% or more above that, or net profit 10% or more above, is "above trend"; as far below is "below trend". It answers "was this quarter better or worse than the company's own recent run?", which consensus does not.

Cash and debt. Profit is an accounting figure; cash is harder to dress up. For each company we show its operating cash flow for the last financial year as a share of that year's net profit (flagged under 50%, or when it is negative despite a profit), and its borrowings at the latest balance sheet against the one six months earlier (flagged at a 25% move). Balance sheets come with the September and March results, cash-flow statements with the March results.

Price since results. The latest close against the last close before the filing (a filing after 3:30 pm counts from the next session). It is a fact about the market's reaction, not advice.

Market cap groups. Large cap is the 100 largest companies by market value and mid cap the next 150 (SEBI's ranking); below that, small cap is ₹5,000 Cr or more, micro cap ₹500 Cr or more, nano cap below.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI